As of 2024-07-27, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 66.94 mil USD. BLUE's TTM EBITDA according to its financial statements is -290.13 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 13.6x - 22.9x | 17.0x |
Forward P/E multiples | 16.9x - 24.5x | 21.4x |
Fair Price | (24.92) - (34.03) | (28.32) |
Upside | -2142.6% - -2889.7% | -2421.2% |
Date | EV/EBITDA |
2024-07-26 | -0.23 |
2024-07-25 | -0.22 |
2024-07-24 | -0.18 |
2024-07-23 | -0.24 |
2024-07-22 | -0.18 |
2024-07-19 | -0.12 |
2024-07-18 | -0.18 |
2024-07-17 | -0.23 |
2024-07-16 | -0.32 |
2024-07-15 | -0.30 |
2024-07-12 | -0.23 |
2024-07-11 | -0.17 |
2024-07-10 | -0.11 |
2024-07-09 | -0.09 |
2024-07-08 | -0.04 |
2024-07-05 | -0.04 |
2024-07-03 | -0.03 |
2024-07-02 | -0.04 |
2024-07-01 | -0.07 |
2024-06-28 | -0.08 |
2024-06-27 | -0.05 |
2024-06-26 | -0.03 |
2024-06-25 | -0.05 |
2024-06-24 | -0.10 |
2024-06-21 | -0.02 |
2024-06-20 | 0.01 |
2024-06-18 | -0.03 |
2024-06-17 | -0.06 |
2024-06-14 | -0.06 |
2024-06-13 | -0.09 |
2024-06-12 | -0.08 |
2024-06-11 | -0.08 |
2024-06-10 | -0.04 |
2024-06-07 | -0.02 |
2024-06-06 | -0.03 |
2024-06-05 | -0.05 |
2024-06-04 | -0.07 |
2024-06-03 | -0.06 |
2024-05-31 | -0.02 |
2024-05-30 | -0.02 |
2024-05-29 | -0.02 |
2024-05-28 | -0.05 |
2024-05-24 | -0.06 |
2024-05-23 | -0.07 |
2024-05-22 | -0.08 |
2024-05-21 | -0.08 |
2024-05-20 | -0.11 |
2024-05-17 | -0.11 |
2024-05-16 | -0.12 |
2024-05-15 | -0.13 |